DELRAY BEACH, Fla., Sept. 21, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that it has appointed Yuval Rabin to its advisory board. Rabin is Managing Partner at Oris Investments and brings on board deep business experience with governments, state and federal processes, and an extensive network and contacts around the globe, including Africa, Arab countries, and Eastern European countries. Rabin lives in Israel, where the Company is currently developing its Easy Check™ non-invasive breath glucose detection device.
